NASDAQ: TTRX
Turn Therapeutics Inc Earnings Dates, Reports, Calls

Turn Therapeutics earnings were N/A for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest TTRX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$1.2M, down N/A from last quarter.

TTRX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

TTRX Return on Equity

Insufficient data to display

TTRX undefined

Insufficient data to display

Be the first to know when TTRX announces earnings.

TTRX undefined

Current Company
0%
Current Industry
6.4%

TTRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARDN/AN/AN/AN/A
ABCL-$113.80M-$167.87MN/A-$0.56
ABUS-$53.13M-$54.25MN/A-$0.29
ABVX-$204.66M-$227.20MN/A-$3.59
AAPGN/A-$161.45MN/A-$2.02

Turn Therapeutics Earnings Reports & History FAQ

What were Turn Therapeutics's earnings last quarter?

Turn Therapeutics (NASDAQ: TTRX) reported Q2 2025 earnings per share (EPS) of -$0.05, up 200% year over year. Total TTRX earnings for the quarter were -$1.24 million. In the same quarter last year, Turn Therapeutics's earnings per share (EPS) was -$0.02.

If you're new to stock investing, here's how to buy Turn Therapeutics stock.

Is Turn Therapeutics profitable or losing money?

As of the last Turn Therapeutics earnings report, Turn Therapeutics is currently losing money. Turn Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was N/A, a N/A decrease year over year.

What was TTRX's earnings growth in the past year?

As of Turn Therapeutics's earnings date in Q4 2025, Turn Therapeutics's earnings has grown year over year. TTRX earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.